NLRP3 and colorectal cancer: While some authors have shown a clear association between high levels of inflammasome activity and poor survival, for example in colorectal cancer and laryngeal squamous cell carcinoma [14,134], others have proposed NLRP3 inflammasome-dependent pyroptosis induction as a therapy for cases of acute myeloid leukemia or colorectal cancer [135].